Climet Instruments Company has announced a strategic partnership with Phizzle, Inc. that aims to deliver enhanced value to users of Climet's particle counters and air samplers, with emphasis on data integrity, risk mitigation, and labor savings. The partnership introduces a unique value proposition that combines Total Cost of Ownership with Return on Investment, representing what the companies describe as the industry's first such combined offer.
Jim Strachan, Climet's General Manager, stated that the partnership takes the company's value proposition to the next level, building on Climet's reputation for providing pharmaceutical-grade cleanroom particle counters and microbial air samplers that minimize failure investigations and deviation reports. The collaboration follows a year of joint work between the two companies and addresses key challenges in pharmaceutical manufacturing operations.
A key advantage of this partnership is the integration of Phizzle's GxP-compliant software with Climet's product line, allowing for remote operation and automated routine monitoring of Climet's particle counters. The software seamlessly captures sample data and pushes it directly to any Laboratory Information Management System, eliminating manual data collection and entry while facilitating the digitization of pharmaceutical manufacturing processes. This integration extends to Climet's continuous monitoring particle counters, portable particle counters, and the CI-97 intelligent microbial air sampler.
By leveraging Phizzle's software to capture and route metadata from these devices, pharmaceutical manufacturers can expect further reduction in deviation reports and significant improvement in audit readiness. Phizzle CEO Ben Davis noted that the partnership addresses key pain points like data integrity and manual sampling while creating an ROI that pays for the investment in less than 12 months. The companies claim that the ROI frequently exceeds 1000%, with the solution promising to streamline operations, reduce errors, and improve compliance with regulatory standards.
The impact on the pharmaceutical manufacturing industry could be substantial, as the Climet-Phizzle solution addresses critical issues that have long challenged manufacturers. Pharmaceutical manufacturers interested in exploring the benefits of this integrated solution can review the ROI generated by pairing Climet with Phizzle through resources available at https://www.climet.com. The partnership represents a significant step toward more automated, efficient, and compliant pharmaceutical manufacturing operations, with both companies emphasizing their complementary strengths in hardware and software solutions.
